Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study (STAFE)
Sponsor: University Hospital, Lille
Summary
The investigators hypothesized that the use of biomarkers of invasive fungal infections would increase the percentage of early discontinuation of empirical antifungal therapy and thus reduce the duration of treatment in ICU patients.
Official title: Fungal Biomarkers to Reduce Duration of Empirical Antifungal Therapy: a Randomized Comparative Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2014-07
Completion Date
2016-12
Last Updated
2026-04-22
Healthy Volunteers
No
Conditions
Interventions
Biomarker group
use of invasive fungal disease biomarkers (β-1,3-glucan, mannan/anti-mannan antibodies)
Locations (1)
ICU, Salengro Hospital, University Hospital of Lille
Lille, Nord, France